Skip to search formSkip to main contentSkip to account menu

tulobuterol

Known as: 1-(o-chlorophenyl)-2-tert-butylaminoethanol, 2-chloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol, alpha-((tert-butylamino)methyl)-o-chlorobenzyl alcohol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Tulobuterol permeation through skin from various transdermal delivery systems has been compared for the bioequivalence among… 
2006
2006
1 Although the clinical effects of the tulobuterol patch have been reported to include an increase in morning peak expiratory… 
2005
2005
ABSTRACT Background Transdermal patches containing tulobuterol, slow-releasing β2-agonist patches, are now widely used in the… 
Highly Cited
2004
Highly Cited
2004
SummaryWe have studied the pharmacokinetics of tulobuterol given transdermally or by aerosol inhalation in healthy male… 
2002
2002
1. Recently, a patch formulation of tulobuterol, a β‐adrenoceptor (AR) agonist, has been developed using a transdermal delivery… 
1995
1995
BACKGROUND Recently, a novel percutaneous adhesive tulobuterol preparation, HN-078, has been developed and tests using healthy… 
1987
1987
The influence of tulobuterol and fenoterol upon mucociliary clearance (mC) and airway obstruction was investigated in 8 patients… 
1963
1963
Synthesis of a series of N‐alkyl derivatives of 2‐amino‐1‐p‐aminophenyl‐ethanolamine has been described, and the results of…